⚠️ Disclaimer

MOTS-C is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Pairs with SS-31 (another mitochondrial-targeting peptide) for enhanced mitochondrial biogenesis, and with 5-Amino-1MQ for comprehensive metabolic optimization. Proper stacking requires understanding each compound's mechanism and timing.

What Is MOTS-C Stacking?

Stacking means combining MOTS-C with one or more complementary peptides to potentially achieve synergistic effects. Because different peptides work through different mechanisms, strategic combinations can target multiple pathways simultaneously.

MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.

What Is the Best MOTS-C Stack?

Pairs with SS-31 (another mitochondrial-targeting peptide) for enhanced mitochondrial biogenesis, and with 5-Amino-1MQ for comprehensive metabolic optimization.

This combination is popular because it targets multiple mechanisms without significant overlap in side-effect profiles.

How Does MOTS-C Stack With 5-Amino-1MQ?

5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor that works through Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NA.

Combined with MOTS-C's effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility, this stack covers fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects as well.

Typical stacking protocol: MOTS-C at 5-10 mg per week 2-3 times weekly alongside 5-Amino-1MQ at 150-500 mcg subcutaneous, 50-100 mg oral once to twice daily. See our 5-Amino-1MQ guide for details.

How Does MOTS-C Stack With SS-31?

SS-31 (Elamipretide (SS-31)) is a Mitochondrial-targeting tetrapeptide that works through Selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure and enhancing electron transfer efficiency. Reduces c.

Combined with MOTS-C's effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility, this stack covers improved muscle strength, enhanced cardiac function, increased ATP production, reduced oxidative stress, restored age-related mitochondrial dysfunction as well.

Typical stacking protocol: MOTS-C at 5-10 mg per week 2-3 times weekly alongside SS-31 at 4-40 mg daily (subcutaneous); 0.01-0.25 mg/kg/hour IV daily subcutaneous or weekly IV infusion. See our SS-31 guide for details.

How Does MOTS-C Stack With AOD-9604?

AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog that works through Activates beta-3 adrenergic receptors in adipose tissue, triggering cAMP-mediated lipolysis and release of stored fat for energy. Suppresses lipogenes.

Combined with MOTS-C's effects on improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility, this stack covers fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation as well.

Typical stacking protocol: MOTS-C at 5-10 mg per week 2-3 times weekly alongside AOD-9604 at 250-1000 mcg daily once daily, ideally morning fasted. See our AOD-9604 guide for details.

How Do You Time a MOTS-C Stack?

When stacking, timing each injection based on half-life is important. MOTS-C has a half-life of not established in humans, which influences when to administer relative to other compounds.

Some researchers inject all peptides at the same time; others stagger by 15-30 minutes. There's limited data on whether timing within the same session matters significantly.

What Should You NOT Stack With MOTS-C?

Avoid stacking peptides with similar mechanisms of action at full doses — this can lead to receptor desensitization without proportional benefit. Also avoid combining compounds where side-effect profiles overlap significantly.

When in doubt, introduce one new compound at a time to isolate its effects before building a full stack.

Calculate Your MOTS-C Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MOTS-C.

Open Calculator →

Bottom Line on MOTS-C Stacking

Pairs with SS-31 (another mitochondrial-targeting peptide) for enhanced mitochondrial biogenesis, and with 5-Amino-1MQ for comprehensive metabolic optimization. Start with a single compound, assess response, then add complements.

See our stacking and cycling guide for general principles.

Complete Guide

MOTS-c: The Metabolic Mitochondrial Peptide

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research MOTS-C, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse MOTS-C

Particle → Browse MOTS-C

Limitless → Browse MOTS-C

Frequently Asked Questions

What is MOTS-C?

MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C) is a Mitochondrial-derived peptide, metabolic regulator. Encoded by the 12S rRNA region of the mitochondrial genome; naturally produced in response to stress, exercise, and aging. It is researched for improved insulin sensitivity, glucose metabolism, fat loss, lean muscle preservation, exercise capacity enhancement, anti-aging, metabolic flexibility.

What is the recommended MOTS-C dosage?

Common dosages: 5-10 mg per week administered 2-3 times weekly via subcutaneous injection. Cycle length: 8-12 weeks with 8-12 week breaks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.

What are the side effects of MOTS-C?

Generally well-tolerated. Mild injection site reactions and transient digestive disturbances at higher doses. CB4211 analog showed good tolerability in a 4-week human trial.

Is MOTS-C safe?

MOTS-C has shown a favorable safety profile in research. Not FDA-approved. Listed by FDA as unlawful for compounding. Available as research chemical only. All research should follow appropriate safety protocols.